U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H27N5O3.ClH
Molecular Weight 421.921
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BAMIFYLLINE HYDROCHLORIDE

SMILES

Cl.CCN(CCO)CCN1C(CC2=CC=CC=C2)=NC3=C1C(=O)N(C)C(=O)N3C

InChI

InChIKey=PDBXHPORMXSXKO-UHFFFAOYSA-N
InChI=1S/C20H27N5O3.ClH/c1-4-24(12-13-26)10-11-25-16(14-15-8-6-5-7-9-15)21-18-17(25)19(27)23(3)20(28)22(18)2;/h5-9,26H,4,10-14H2,1-3H3;1H

HIDE SMILES / InChI

Molecular Formula C20H27N5O3
Molecular Weight 385.4601
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Bamifylline (or bamiphylline), a selective antagonist of the A1 adenosine receptor, was studied in the therapy of asthmatic syndromes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P30542
Gene ID: 134.0
Gene Symbol: ADORA1
Target Organism: Homo sapiens (Human)
PubMed

PubMed

TitleDatePubMed
Single channel studies of the ATP-regulated potassium channel in brain mitochondria.
2009-08
Catecholaminergic neuron survival: getting hooked on GDNF.
2008-07
In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function.
2008-06-01
UC blood infection with clinical strains of Mycobacterium tuberculosis: a novel model.
2007
Isolation and culture of biliary epithelial cells from bile duct remnants of patients with biliary atresia.
2004-09
Tumor necrosis factor-alpha in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women.
2004
Acute generalized exanthematous pustulosis induced by ingestion of bamifylline.
2002-11
Bamiphylline improves exercise-induced myocardial ischemia through a novel mechanism of action.
1993-08
Patents

Sample Use Guides

600 mg b.d. for 15 days
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:45:14 GMT 2025
Edited
by admin
on Mon Mar 31 17:45:14 GMT 2025
Record UNII
66466QLM3S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BAMIFYLLINE HYDROCHLORIDE
MART.   MI   USAN   WHO-DD  
USAN  
Official Name English
8102 CB
Preferred Name English
1H-PURINE-2,6-DIONE, 7-(2-(ETHYL(2-HYDROXYETHYL)AMINO)ETHYL)-3,7-DIHYDRO-1,3-DIMETHYL-8-(PHENYLMETHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
8102-CB
Code English
AC 3810
Code English
1H-PURINE-2,6-DIONE, 7-(2-(ETHYL(2-HYDROXYETHYL)AMINO)ETHYL)-3,7-DIHYDRO-1,3-DIMETHYL-8-(PHENYLMETHYL)-, MONOHYDROCHLORIDE
Systematic Name English
BAX-2739Z
Code English
8-Benzyl-7-[2-[ethyl(2-hydroxyethyl)amino]ethyl]theophylline monohydrochloride
Systematic Name English
BAX 2739Z
Code English
BAMIFYLLINE HYDROCHLORIDE [USAN]
Common Name English
BAMIFYLLINE HCL
Common Name English
AC-3810
Code English
BAMIFYLLINE HYDROCHLORIDE [MART.]
Common Name English
Bamifylline hydrochloride [WHO-DD]
Common Name English
BAMIFYLLINE HYDROCHLORIDE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C319
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
243-967-6
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
CAS
20684-06-4
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
PUBCHEM
68549
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
EPA CompTox
DTXSID4048721
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
SMS_ID
100000091601
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
FDA UNII
66466QLM3S
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
DRUG BANK
DBSALT002675
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
RXCUI
236152
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY RxNorm
NCI_THESAURUS
C76574
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
MERCK INDEX
m2218
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY Merck Index
MESH
C006683
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
ChEMBL
CHEMBL2110760
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
EVMPD
SUB12981MIG
Created by admin on Mon Mar 31 17:45:15 GMT 2025 , Edited by admin on Mon Mar 31 17:45:15 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY